Today: 1 May 2026
US Stock Market Today (Dec. 25, 2025): Wall Street Closed for Christmas After Dow and S&P 500 Record Highs; Santa Rally Watch, Key Movers, and 2026 Forecasts
25 December 2025
7 mins read

US Stock Market Today (Dec. 25, 2025): Wall Street Closed for Christmas After Dow and S&P 500 Record Highs; Santa Rally Watch, Key Movers, and 2026 Forecasts

Updated: 10:18 a.m. ET, Thursday, December 25, 2025 — The U.S. stock market is closed today for Christmas Day, with the New York Stock Exchange and Nasdaq both observing the holiday shutdown. Regular trading resumes Friday, Dec. 26.

Even with cash markets dark, Wall Street is far from quiet. Investors are digesting a record-setting Christmas Eve session, tracking a fresh batch of corporate headlines that broke into the holiday, and debating whether the year-end “Santa Claus rally” can extend gains into the final stretch of 2025—and possibly set the tone for 2026. Reuters

Market status today: why you won’t see U.S. stock quotes move

  • NYSE: Christmas Day is a market holiday; NYSE markets are closed today.
  • Nasdaq: U.S. markets are closed on Dec. 25, following an early close at 1:00 p.m. ET on Dec. 24.
  • U.S. fixed income: SIFMA recommended an early close at 2:00 p.m. ET on Dec. 24 and a full close on Dec. 25 for U.S. dollar-denominated fixed-income markets (recommendations, though firms can decide individually).

In other words: today is a pause in cash equities and much of the traditional U.S. market plumbing, which often amplifies the importance of the last full/partial session and increases attention on what might happen when liquidity returns.

What happened in the last session: Dow and S&P 500 finished at record highs

On Wednesday, Dec. 24 (Christmas Eve)—a holiday-shortened session—U.S. stocks closed higher, with two major benchmarks notching record closing highs:

  • Dow Jones Industrial Average: 48,731.16 (+0.60%)
  • S&P 500: 6,932.05 (+0.32%)
  • Nasdaq Composite: 23,613.31 (+0.22%)

The tone was broadly constructive heading into the holiday break, helped by a rebound in AI-linked names after a bout of valuation/capex anxiety earlier in the month and by the market’s ongoing bet that rate cuts remain part of the 2026 story.

Holiday liquidity was extremely thin—and that matters

Trading volume underscored just how “holiday” the session really was: 7.61 billion shares changed hands on U.S. exchanges versus a 20-day average of 16.21 billion, according to Reuters. Reuters

Thin liquidity can make market moves look deceptively calm (or suddenly jumpy) and is one reason many strategists caution against over-reading late-December price action—especially when positioning and rebalancing flows can dominate the tape.

The drivers: AI optimism, rate-cut expectations, and “resilient economy” signals

Reuters attributed the late-year climb partly to a bounce back in AI-related names, after last week’s selloff sparked by concerns that heavy capital expenditures could pressure profitability—an issue that remains a key debate into 2026.

On the macro side, recent data has kept the “soft landing” narrative alive. Reuters noted that markets were still pricing roughly 50 basis points of Federal Reserve rate cuts next year (while expectations for a January cut were described as low). Reuters

Meanwhile, AP reported that initial jobless claims for the week ending Dec. 20 fell to 214,000 (down 10,000), and also highlighted a surprisingly strong 4.3% annualized GDP print for the third quarter—data points that feed the view that the economy has remained sturdier than many feared earlier in the cycle.

Today’s big stock stories (even with the market closed)

With no U.S. cash session today, the “stock market news” spotlight shifts to what happened in the final pre-holiday session—and to company announcements that can shape sentiment going into Friday.

1) Big deal: Sanofi agrees to buy Dynavax for about $2.2 billion

Dynavax surged in the shortened session after Sanofi said it would acquire the vaccine maker for roughly $2.2 billion, a move aimed at strengthening Sanofi’s adult vaccine portfolio.

2) Chips and AI: Nvidia’s Groq licensing deal is the latest “deal-spree” twist

Nvidia made headlines with a strategic non-exclusive technology licensing agreement tied to AI inference chip technology, alongside executive hires from Groq—an approach Reuters framed as part of a broader Big Tech shift toward licensing/acqui-hire structures rather than straightforward acquisitions.

Why it matters for markets: This reinforces a key late-2025/early-2026 theme: Wall Street increasingly treats “AI infrastructure and inference” as a multi-year capex cycle—bullish for parts of semiconductors and data-center supply chains, but also a source of valuation risk if returns on spending disappoint. Reuters

3) Micron: another signal that the AI hardware cycle is still driving winners

Micron shares rose again and ended at a record close of $286.68 in the holiday session, extending a rally after issuing a strong forecast the prior week, according to Reuters.

4) Nike and Intel: notable single-stock headlines from the shortened session

  • Nike jumped after disclosure that Apple CEO Tim Cook (a Nike board member) bought roughly $3 million of Nike shares, Reuters reported.
  • Intel slipped after a report that Nvidia halted tests related to Intel’s 18A process, according to Reuters.

5) GLP-1 and healthcare: Novo Nordisk’s “Wegovy pill” approval

Novo Nordisk announced that Wegovy® pill was approved in the U.S. as an oral GLP‑1 option for weight management, with the company expecting a launch in early January 2026.

Healthcare and weight-loss drug competition remains a major market narrative—particularly given how much earnings growth and index leadership have concentrated in a relatively small group of mega-cap and high-growth themes.

The Federal Reserve backdrop: where policy stands heading into 2026

The Fed’s policy path remains one of the market’s main “macro levers.” In its Dec. 10, 2025 statement, the Federal Open Market Committee said it lowered the target range for the federal funds rate to 3.50%–3.75%. Federal Reserve

From there, the market debate turns to how far and how fast additional cuts might come. Reuters’ late-December reporting emphasized that investors are still watching for a dovish-enough Fed stance in 2026 to support risk assets without reigniting inflation.

And in one example of the kind of “street-level” forecasting investors track into year-end: UBS said it maintained a view for a 25-basis-point cut by the end of the first quarter of 2026. Korea

Volatility, oil, and the “feel” of the market: what cross-asset signals are saying

Even without a live U.S. cash session today, cross-asset indicators are shaping the narrative investors will bring into Friday.

Volatility remains subdued

Reuters described the VIX—the market’s “fear gauge”—as holding near levels not seen since December 2024, a sign of calmer implied volatility heading into year-end. Reuters

Schwab’s market update also showed the VIX around 13.96 during the pre-holiday period.

MarketWatch similarly highlighted a VIX dip below 14 around the Christmas Eve record close.

Oil stayed soft

AP reported U.S. crude closing around $58.35 a barrel and Brent around $61.80, levels that help keep a lid on headline inflation pressure—even as investors remain sensitive to geopolitics and supply risks.

Santa Claus rally watch: what history says about Dec. 26

With markets reopening Friday, the calendar itself becomes a talking point.

Reuters noted that the “Santa Claus rally” is typically defined as gains in the last five trading days of the year and the first two of January—and said the period began on Dec. 24 and runs through Jan. 5 this year. Reuters

One statistic getting fresh attention on Dec. 25: MarketWatch cited Bespoke Investment Group data indicating Dec. 26 has historically been the most consistently positive trading day of the year for the S&P 500 (with the index down only a handful of times in decades of observations and with relatively small declines).

Important context for readers: Seasonal patterns can influence sentiment, but they don’t override fundamentals. With liquidity often still light between Christmas and New Year’s, headlines and positioning can exaggerate moves in either direction.

2026 outlook: what strategists are forecasting—and what could derail it

With the S&P 500 on track for another strong year (Reuters said it’s up over 17% in 2025 with only a few sessions left), the big question becomes whether the market can deliver a fourth straight year of sizable gains.

The bullish case: earnings breadth + AI demand + rate cuts

Reuters framed three pillars many bulls point to for 2026:

  1. Earnings growth: LSEG projections cited by Reuters put S&P 500 earnings up over 15% in 2026, following a projected 13% rise in 2025.
  2. AI spending momentum: continued infrastructure buildout and deployment.
  3. More Fed cuts: not too many, not too few—enough to support valuation without signaling recession.

UBS echoed a constructive stance, forecasting S&P 500 EPS of $305 in 2026 and projecting the index could reach 7,700 by end‑2026 (UBS CIO house view).

The “consensus-ish” view: still higher, but with real risks

A Reuters poll of brokerage expectations said the S&P 500 could rise nearly 12% to 7,490 by end‑2026, while also flagging risks including inflation, stretched valuations, and tariff tensions that could trigger corrections.

Reuters also pointed to a familiar constraint for 2026: valuations are already elevated enough that markets may need profits—not just multiples—to do the heavy lifting from here.

Wildcards investors are watching

Late-December Reuters reporting highlighted several swing factors:

  • AI capex vs. AI payoff: if companies pull back spending or investors lose confidence in returns, the market could flatten or dip.
  • Tariffs and U.S.–China relations: less dominant than earlier in 2025, but still capable of moving markets quickly.
  • Fed leadership and independence questions: Reuters reported that investors are watching for a potential Fed chair choice early in 2026 and are sensitive to how that could shape perceived policy independence.

What to watch next when Wall Street reopens Friday

With today’s closure, Friday’s open becomes the next key “checkpoint” for market tone—even if the economic calendar is quiet.

Here are the practical catalysts to track as trading returns:

  • Liquidity and volatility at the open: after a holiday shutdown, spreads and intraday swings can behave differently than in a typical session.
  • No major scheduled U.S. releases on Dec. 26: Schwab’s “week ahead” noted no major earnings or economic data expected on Dec. 26 (and none on Dec. 25). Schwab Brokerage
  • Late-December positioning: watch whether leadership broadens beyond mega-cap tech/AI and whether financials keep contributing (a tailwind noted by Reuters in the final pre-holiday session).
  • Santa rally narrative vs. reality: Dec. 26’s historical pattern is supportive, but the market will ultimately follow positioning, rates, and earnings expectations.

Bottom line for Dec. 25: the market is closed, but the story is still moving

As of 10:18 a.m. ET on Dec. 25, U.S. stocks aren’t trading—but Wall Street is still very much in “price-discovery mode” through the lens of record closes, AI and chip headlines, and a growing body of 2026 forecasts that hinge on earnings delivery and a Fed that can ease without reigniting inflation. Korea

When the bell returns on Friday, Dec. 26, investors will be looking for confirmation that the late-December momentum is more than a holiday mirage—and that the path into 2026 can justify today’s optimistic pricing.

Stock Market Today

  • Cardano (ADA) Prospects: Governance Focus and Potential for Millionaire Returns
    April 30, 2026, 10:39 PM EDT. Cardano (ADA), a governance-focused cryptocurrency launched in 2017 by Ethereum co-founder Charles Hoskinson, once soared to $3.10 but now trades near $0.25. It uses an energy-efficient proof-of-stake blockchain, Ouroboros, enabling faster transaction speeds than Ethereum and requiring rigorous peer reviews for projects to enhance security and scalability. Despite this, its developer community remains small compared to Ethereum's. Cardano's unique governance approach and new features like the Midnight sidechain could attract regulated industries. However, to turn $10,000 into $1 million again, ADA's price must rise 100-fold to $25, pushing its market cap beyond Ethereum but below Bitcoin's. The path to such growth faces significant challenges amid market competition and adoption hurdles.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts
Previous Story

Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Rocket Lab Stock (RKLB) Surges Into 2026: Space Force Satellite Deal, Record 2025 Launches, Analyst Forecasts, and Key Risks
Next Story

Rocket Lab Stock (RKLB) Surges Into 2026: Space Force Satellite Deal, Record 2025 Launches, Analyst Forecasts, and Key Risks

Go toTop